Advanced search
Publication Cover
Expert Review of Vaccines Volume 23, 2024 - Issue 1
Submit an article Journal homepage
517
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Immunogenicity and safety of boosting with a recombinant two-component SARS-CoV-2 vaccine: two randomized, parallel-controlled, phase 2 studies

Abundio Balgosa The Health Centrum, Roxas City, PhilippinesView further author information
,
Suad Hannawib United Arab Emirates – Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, UAEView further author information
,
Wen-Li Chenc Department of Rehabilitation Medicine, ZhongDa Hospital, Southeast University, Nanjing, ChinaView further author information
,
Alaa Abuqutab United Arab Emirates – Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, UAEView further author information
,
Linda Safeldinb United Arab Emirates – Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, UAEView further author information
,
Aala Hassanb United Arab Emirates – Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, UAEView further author information
,
Ahmad Alamadib United Arab Emirates – Al Kuwait-Dubai (ALBaraha) Hospital, Dubai, UAEView further author information
,
Louie Tiradord St. Paul’s Hospital, Iloilo City, PhilippinesView further author information
,
Anjuli May Jaend St. Paul’s Hospital, Iloilo City, PhilippinesView further author information
,
Ralph Elvi Villalobose University of the Philippines – Philippine General Hospital, Manila, PhilippinesView further author information
,
Chen Mof Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Zi-Jing Yuef Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Ying Maf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Qing-Shuang Wangf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Ren-Du Wenf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Zheng Yaof Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Jia-Ping Yuf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Wen-Rong Yaof Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Jian-Hui Zhangf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, ChinaView further author information
,
Kun-Xue Hongf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, China;g School of Public Health, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, ChinaView further author information
,
Yong Liuf Research & Development Department, Jiangsu Recbio Technology Co., Ltd, China;g School of Public Health, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, ChinaCorrespondence[email protected]
View further author information
&
Jing-Xin Lig School of Public Health, National Vaccine Innovation Platform, Nanjing Medical University, Nanjing, China;h Jiangsu Provincial Medical Innovation Center, National Health Commission Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 419-431 | Received 11 Jan 2024, Accepted 20 Mar 2024, Published online: 02 Apr 2024

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.